Credicorp turns $100 into $918 in 20 years, beats market by 2.6%
- $100 invested in Credicorp 20 years ago is now worth $918.01
- Average annual return of 11.76% outperformed the market by 2.6%
- Current share price of $385.38 drives a $30.61 billion market cap

*this image is generated using AI for illustrative purposes only.
Credicorp (NYSE: BAP) shares have delivered a total return of $918.01 on a hypothetical $100 investment made 20 years ago. The Peruvian financial holding company’s stock price stood at $385.38 at the time of writing, reflecting significant long-term capital appreciation.
Long-term performance metrics
The data highlights Credicorp’s ability to generate consistent value for shareholders over two decades. The stock has outperformed the broader market by 2.6% on an annualized basis during this period. This performance resulted in an average annual return of 11.76% for investors who maintained their position throughout the timeframe.
| Metric | Value |
|---|---|
| Initial Investment | $100 |
| Current Value | $918.01 |
| Average Annual Return | 11.76% |
| Market Outperformance | 2.6% (annualized) |
| Current Share Price | $385.38 |
| Market Capitalization | $30.61 billion |
Market capitalization and scale
Credicorp currently holds a market capitalization of $30.61 billion. The substantial growth in share price from the initial investment level to the current valuation underscores the compounding effect of equity investments in established financial institutions. The company’s sustained outperformance relative to the market suggests strong operational execution and favorable market conditions over the long term.
What the numbers show
The divergence between the absolute return and the market benchmark provides a clear picture of relative strength. While the stock generated an 11.76% average annual return, the explicit note that it outperformed the market by 2.6% annually implies that the broader market index returned approximately 9.16% per year over the same period. This gap illustrates how consistent alpha generation, even if modest in percentage terms, compounds significantly over a 20-year horizon to produce nearly ninefold returns on initial capital.
How might recent regulatory changes in Peru's banking sector impact Credicorp's ability to sustain its historical 11.76% annual return?
What specific expansion strategies is Credicorp pursuing to maintain its 2.6% annualized market outperformance as it approaches a $30 billion market cap?
How could shifting interest rate policies in Latin America affect Credicorp's net interest margins and future dividend distributions?

























